Abstract
The matrix metalloproteinase-2 (MMP-2), over-expressed in most cancers, induces TH2 polarization by conditioning dendritic cells to over-express OX40L and down-regulate IL-12p70 through the degradation of the type-I IFN receptor IFNAR1. Elucidating mechanisms underlying detrimental tumor-associated type-2 responses represent a crucial step in designing effective immune therapies to treat cancer patients.
Original language | English |
---|---|
Pages (from-to) | 109-111 |
Number of pages | 3 |
Journal | OncoImmunology |
Volume | 1 |
Issue number | 1 |
DOIs |
|
State | Published - 2012 |
Externally published | Yes |